CA2262267C - Compositions pharmaceutiques contre la migraine et methode d'utilisation - Google Patents

Compositions pharmaceutiques contre la migraine et methode d'utilisation Download PDF

Info

Publication number
CA2262267C
CA2262267C CA 2262267 CA2262267A CA2262267C CA 2262267 C CA2262267 C CA 2262267C CA 2262267 CA2262267 CA 2262267 CA 2262267 A CA2262267 A CA 2262267A CA 2262267 C CA2262267 C CA 2262267C
Authority
CA
Canada
Prior art keywords
tramadol
migraine
antiemetic
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2262267
Other languages
English (en)
Other versions
CA2262267A1 (fr
Inventor
Marc Raber
Helmut Momberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma GmbH and Co KG
Original Assignee
Viatris GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris GmbH and Co KG filed Critical Viatris GmbH and Co KG
Publication of CA2262267A1 publication Critical patent/CA2262267A1/fr
Application granted granted Critical
Publication of CA2262267C publication Critical patent/CA2262267C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2262267 1998-02-20 1999-02-19 Compositions pharmaceutiques contre la migraine et methode d'utilisation Expired - Fee Related CA2262267C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7533298P 1998-02-20 1998-02-20
US60/075,332 1998-02-20

Publications (2)

Publication Number Publication Date
CA2262267A1 CA2262267A1 (fr) 1999-08-20
CA2262267C true CA2262267C (fr) 2007-05-08

Family

ID=29581917

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2262267 Expired - Fee Related CA2262267C (fr) 1998-02-20 1999-02-19 Compositions pharmaceutiques contre la migraine et methode d'utilisation

Country Status (1)

Country Link
CA (1) CA2262267C (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108930D0 (en) * 2001-04-10 2001-05-30 Boots Co Plc Therapeutic agents
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
EP2240022B1 (fr) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Comprimés à deux couches contenant oxycodone et promethazine
CA2767576C (fr) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Compositions pharmaceutiques refermant un antiemetique et un analgesiqueopioide
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物

Also Published As

Publication number Publication date
CA2262267A1 (fr) 1999-08-20

Similar Documents

Publication Publication Date Title
US6376550B1 (en) Pharmaceutical compositions containing tramadol for migraine
KR100438133B1 (ko) Ace억제제라미프릴및디히드로피리딘화합물을함유하는신규의제약조성물
US20110274628A1 (en) Nicotine-containing pharmaceutical compositions
JP3194734B2 (ja) 迅速作用性選択的セロトニン再摂取阻害剤を用いた性的不全の処置方法
AU748993B2 (en) Pharmaceutical combinations containing tramadol
CA2336095A1 (fr) Formes posologiques contenant de l'apomorphine pour ameliorer un dysfonctionnement de l'erection chez l'homme
TWI331920B (en) Unit dosage form for relieving or treating constipation in human patients
CA2464261A1 (fr) Forme posologique contenant de l'apomorphine pour l'amelioration de la dyserection male
CA2262267C (fr) Compositions pharmaceutiques contre la migraine et methode d'utilisation
JP5561885B2 (ja) ミルタザピンの新しい配合物
US20060269598A1 (en) Antihistaminic/Decongestant/Anticholinergic Compositions and Methods of Use
JPH0149124B2 (fr)
HU206830B (en) Process for producing pharmaceutical compositions containing pafantagonists for treating heart diseases produced by diminished beta-receptor-stimulant
TW200405818A (en) Side effect alleviator of diclofenac
MXPA00007922A (en) Pharmaceutical combinations containing tramadol
JP2002541100A (ja) ヒトの性的応答を調節するための方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180219